Overexpression of JAKMIP1 associates with Wnt/beta-catenin pathway activation and promotes cancer cell proliferation in vitro

Biomedicine and Pharmacotherapy

Volumn 67, Issue 3, 2013, Pages 228-234

  Okai, Isaac ^a   Wang, Lan ^a   Gong, Linlin ^a   Arko Boham, Benjamin ^a   Hao, Lihong ^a   Zhou, Xin ^a   Qi, Xiaoyu ^a   Hu, Jun ^a   Shao, Shujuan ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

JAKMIP1; Lung cancer; Wnt

Indexed keywords

BETA CATENIN; JANUS KINASE; JANUS KINASE AND MICROTUBULE INTERACTING PROTEIN 1; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; CANCER CELL; CELL PROLIFERATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BETA CATENIN; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; RNA-BINDING PROTEINS; WNT SIGNALING PATHWAY;

EID: 84875499494     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2013.01.003     Document Type: Article

References (41)

1. Logan C.Y., Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004, 20:781-810. Pubmed [15473860].
2. Macdonald B.T., Tamai K., He X. Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009, 17(1):9-26. Pubmed [19619488].
3. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006, 127:469-480. Pubmed [17081971].
4. Konigshoff M., Eickelberg O. WNT signaling in lung disease: a failure or a regeneration signal?. Am J Respir Cell Mol Biol 2010, 42(1):21-31. Pubmed [19329555].
5. Moon R.T., Kohn A.D., De Ferrari G.V., Kaykas A. Wnt and β-catenin signalling: diseases and therapies. Nat Rev Genet 2004, 5:691-701. Pubmed [15372092].
6. Nusse R., Varmus H.E. Wnt genes. Cell 1992, 69:1067-1073. Pubmed [1617723].
7. Chen X., Yang J., Evans M.P., et al. Wnt signaling: the good and bad. Acta Biochim Biophys Sin 2008, 40:577. Pubmed [18604449].
8. Moon T.R., Kohn D.A., Ferrari V.G., et al. Wnt and β-catenin signaling: diseases and therapies. Nat Rev Cancer 2004, 5:689-699. Pubmed [15372092].
9. Plasencia C.P., Gonzalez A.D., Tavera B.A. Second hit in cervical carcinogenesis process: involvement of Wnt/beta catenin pathway. Int Arch Med 2008, 1:1-8. Pubmed [18606007].
10. Polakis P. Wnt signaling cancer. Genes Dev 2000, 14:1837-1851. Pubmed [10921899].
11. Chong Z.Z., Li F., Maiese K. Employing new cellular therapeutic targets for Alzheimer's disease: a change for the better?. Curr Neurovasc Res 2005, 2:55-72. Pubmed [16181100].
12. Tanir H.G., Demirezen S., Beksac M.S. Relation of the Wnt/β-catenin signaling pathway with gynecological cancers. Turk J Biol 2010, 34:227-234.
13. Yeh T.C., Pellegrini S. The Janus Kinase family of Protein Tyrosine Kinases and their role in signaling. Cell Mol Life Sci 1999, 55:1523-1534. Pubmed [10526570].
14. Steindler C., Li Z., Algarte M., Alcover A., Libri V., Ragimbeau J., Pellegrini S. Jakmip1 (Marlin-1) defines a family of proteins interacting with Janus kinases and microtubules. J Biol Chem 2004, 279(41):43168-43177. Pubmed [15277531].
15. B receptors. J Cell Biochem 2008, 103:886-895. Pubmed [17668444].
16. B receptors. J Biol Chem 2004, 279(14):13934-13943. Pubmed [14718537].
17. Kohrmann M., Luo M., Kaether C., DesGroseillers L., Dotti C.G., Kiebler M.A. Microtubule-dependent recruitment of Staufen-green fluorescence protein into large RNA-containing granules and subsequent dendritic transport in living hippocampal neurons. Mol Biol Cell 1999, 10:2945-2953. Pubmed [10473638].
18. Costa V., Conte I., Ziviello C., Casamassimi A., Alfano G., Banfi S., Ciccodicola A. Identification and expression analysis of novel JAKMIP1 transcripts. Gene 2007, 402:1-8. Pubmed [17761393].
19. Raelson J.V., Little R.D., Ruether A., Fournier H., Paquin B., Van Eerdewegh P., et al. Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci. Proc Natl Acad Sci USA 2007, 104:14747-14752. Pubmed [17804789].
20. Nishimura Y., Martin C.L., Lopez A.V., Spence S.J., Alvarez-Retuert A.I., Sigman M., et al. Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways. Hum Mol Genet 2007, 16(14):1682-1698. Pubmed [17519220].
21. van de WeteringM, Sancho E., Verweij C., et al. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002, 111:241-250. Pubmed [12408868].
22. Jho E.H., ZhangT, Domon C., Joo C.K., Freund J.N., Costantini F. Wnt/β-catenin/TCF signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 2002, 22:1172-1183. Pubmed [11809808].
23. Yang X., Xiong Hai, Guan Z.Z., Okai I., Ye Dongmei, Song Y., et al. Higher expression of caveolin-1 inhibits human small cell lung cancer (SCLC) apoptosis in vitro. Cancer Invest 2012, 30(6):453-462. Pubmed [22545709].
24. He X., Semenov M., Tamai K., Zeng X. LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development (Cambridge England) 2004, 131:1663-1677. Pubmed [15084453].
25. Libri V., Sculte D., Stijn A.V., Ragimbeau J., Rogge L., Pellegrini S. Jakmip1 is expressed upon t cell differentiation and has an inhibitory function in cytotoxic T lymphocytes. J Immunol 2008, 181:5847-5856. Pubmed [18941173].
26. Boudny V., Kovarik J. JAK/STAT signaling pathways and cancer. Neoplasma 2002, 49(6):349-355. Pubmed [12584581].
27. Xiong H., Zhang Z.G., Tian X.Q., Sun D.F., Liang Q.C., Zhang Y.J., et al. Inhibition of Jak 1,2/Stat3 induces apoptosis cell cycle arrest and reduces tumor cell invasion in colorectal cancer cells. Neoplasia 2008, 10(3):287-297. Pubmed [18320073].
28. Pikarsky E., Porat R.M., Stein I., Abramovitch R., Amit S., Kasem S., et al. NF-KB functions as a tumour promoter in inflammation associated cancer. Nature 2004, 431:461-466. Pubmed [15329734].
29. Chang C.C., Zhang J., Lombardi L., Neri A., Dalla-Favera R. Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators. Mol Cell Biol 1995, 15:5180-5187. Pubmed [7651435].
30. Rayet B., Gelinas C. Aberrant rel/NFKB genes and activity in human cancer. Oncogene 1999, 18:6938-6947. Pubmed [10602468].
31. Nishikori M. Classical and alternative NF-KB activation pathways and their roles in lymphoid malignancies. J Clin Exp Hematopathol 2005, 45(1):15-24.
32. Paul S., Dey A. Wnt signaling and cancer development: therapeutic implication. Neoplasma 2008, 55:165-176. Pubmed [18348648].
33. Nusse R. Wnt signaling in disease and in development. Cell Res 2005, 15:28-32. Pubmed [15686623].
34. Ueda M., Gemmill R.M., West J., Winn R., Sugita M., Tanaka N., et al. Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas. Br J Cancer 2001, 85:64-68. Pubmed [11437403].
35. Mazieres J., He B., You L., Xu Z., Jablons D.M. Wnt signaling in lung cancer. Cancer Lett 2005, 222:1-10. Pubmed [15837535].
36. Helmbrecht K., Kispert A., Von Wasielewski R., Brabant G. Identification of a Wnt/β-Catenin signaling pathway in human thyroid cells. Endocrinology 2001, 142(12):5261-5266. Pubmed [11713224].
37. Luu H.H., Zhang R., Haydon R.C., Rayburn E., Kang Q., Si W., et al. Wnt/β-Catenin signaling pathway as novel cancer drug targets. Curr Cancer Drug Targets 2004, 4(8):653-671. Pubmed [15578921].
38. Wang A., Yanfeng W.A., Tan C., et al. Phosphorylation of Frizzled-3. J Biol Chem 2006, 281:11603-11609. Pubmed [16513654].
39. Pfeuty B., David-Pfeuty T., Kaneko K. Underlying principles of cell fate determination during G 1 phase of the mammalian cell cycle. Cell Cycle 2008, 7:3246-3257. Pubmed [18843205].
40. Tang Y., Simoneau A.R., Liao W.X., Yi G., Hope C., Liu F., et al. WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells. Mol Cancer Ther 2009, 8(2):458-468. Pubmed [19174556].
41. Tetsu O., McCormick F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999, 398:422-426. Pubmed [10201372].